SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
-8.81%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$228M
AUM Growth
+$228M
(+1.9%)
Cap. Flow
+$31.9M
Cap. Flow
% of AUM
13.97%
Top 10 Holdings %
Top 10 Hldgs %
53.47%
Holding
60
New
15
Increased
13
Reduced
8
Closed
18
Top Buys
| 1 |
Amgen
AMGN
|
$11.7M |
| 2 |
Cardinal Health
CAH
|
$11M |
| 3 |
SHPG
Shire pic
SHPG
|
$10.9M |
| 4 |
Eli Lilly
LLY
|
$10.1M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$9.65M |
Top Sells
| 1 |
DYAX
DYAX CORPORATION
DYAX
|
$25.9M |
| 2 |
Cigna
CI
|
$7.15M |
| 3 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$6.51M |
| 4 |
Sanofi
SNY
|
$6.32M |
| 5 |
AbbVie
ABBV
|
$6.15M |
Sector Composition
| 1 | Healthcare | 88.3% |
| 2 | Industrials | 1.97% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QTNT
1
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $20.9M | 7.64% | 2,373,141 +583,985 | +33% | +$5.14M |
|
|
NEOS
2
DELISTED
Neos Therapeutics, Inc
NEOS
| $13.9M | 5.09% | 1,290,023 +508,509 | +65% | +$5.49M |
|
3
McKesson
MCK
$85.4B
| $13.1M | 4.81% | 83,600 +27,600 | +49% | +$4.34M |
|
|
4
Amgen
AMGN
$155B
| $11.7M | 4.26% | +77,721 | New | +$11.7M |
|
|
ANTH
5
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $11.1M | 4.05% | 3,056,196 +1,677,753 | +122% | +$6.07M |
|
|
6
Cardinal Health
CAH
$35.5B
| $11M | 4.04% | +134,633 | New | +$11M |
|
|
SHPG
7
DELISTED
Shire pic
SHPG
| $10.9M | 3.99% | +63,411 | New | +$10.9M |
|
|
8
Eli Lilly
LLY
$657B
| $10.1M | 3.7% | +140,392 | New | +$10.1M |
|
|
9
Alnylam Pharmaceuticals
ALNY
$58.5B
| $9.65M | 3.53% | +153,778 | New | +$9.65M |
|
|
AGN
10
DELISTED
Allergan plc
AGN
| $9.63M | 3.53% | +35,937 | New | +$9.63M |
|
11
United Therapeutics
UTHR
$13.8B
| $8.62M | 3.15% | +77,317 | New | +$8.62M |
|
|
12
Sanofi
SNY
$121B
| $8.22M | 3.01% | 204,655 -157,307 | -43% | -$6.32M |
|
13
Philips
PHG
$26.2B
| $8M | 2.93% | +280,260 | New | +$8M |
|
|
DMK
14
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $7.74M | 2.83% | 1,262,330 -56,300 | -4% | -$345K |
|
|
VSI
15
DELISTED
Vitamin Shoppe Inc.
VSI
| $6.96M | 2.55% | 224,668 -15,332 | -6% | -$475K |
|
16
Novartis
NVS
$245B
| $6.88M | 2.52% | +94,988 | New | +$6.88M |
|
|
PFNX
17
DELISTED
Pfenex Inc.
PFNX
| $6.52M | 2.39% | 663,176 +215,914 | +48% | +$2.12M |
|
|
AAAP
18
DELISTED
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
| $6.09M | 2.23% | 174,001 -117,876 | -40% | -$4.13M |
|
|
RXDX
19
DELISTED
Ignyta, Inc.
RXDX
| $5.45M | 2% | 805,327 +160,710 | +25% | +$1.09M |
|
|
BEAT
20
DELISTED
BioTelemetry, Inc.
BEAT
| $4.83M | 1.77% | 413,649 +221,894 | +116% | +$2.59M |
|
21
TriNet
TNET
$3.52B
| $4.5M | 1.65% | +313,675 | New | +$4.5M |
|
|
FOMX
22
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $3.73M | 1.37% | 572,628 +156,656 | +38% | +$1.02M |
|
|
FWP
23
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $3.68M | 1.35% | 216,405 +116,405 | +116% | +$1.98M |
|
|
LDRH
24
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
| $3.67M | 1.34% | +144,033 | New | +$3.67M |
|
25
Ascendis Pharma
ASND
$11.8B
| $3.47M | 1.27% | 187,220 -97,565 | -34% | -$1.81M |
|